(S1 (S (S (NP (NN Ras) (NN p21) (NN onco-protein)) (PP (PP (IN in) (NP (NP (DT the) (NN sera)) (PP (IN of) (NP (NP (NNS mice)) (VP (VBG carrying) (NP (DT an) (ADJP (RB experimentally) (VBN induced)) (NN tumor))))))) (CC and) (PP (IN in) (NP (JJ human) (NN cancer) (NNS patients))))) (. .)))
(S1 (S (NP (PRP We)) (VP (VBP have) (VP (VBN established) (NP (NP (DT a) (JJ model) (NN system)) (S (VP (TO to) (VP (VB detect) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN ras) (NN p21))) (PP (IN in) (NP (NP (DT the) (NN sera)) (PP (IN of) (NP (NP (NN Balb/c) (NNS mice)) (VP (VBG carrying) (NP (NP (NNS tumors)) (VP (VBN induced) (PP (IN by) (NP (NP (DT a) (NN mouse) (NN cell) (NN line)) (VP (VBN transformed) (PP (IN with) (NP (NP (DT the) (NN Harvey) (JJ murine) (NN sarcoma) (NN virus)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (DT a) (NN helper) (NN Friend) (JJ murine) (NN leukemia) (NN virus)))))))))))))))))))))))) (. .)))
(S1 (S (S (SBAR (IN As) (S (VP (VBN determined) (PP (IN by) (NP (NP (NP (NN ELISA)) (CC and) (NP (NN immunoblot))) (NNS assays)))))) (, ,) (NP (NP (NN ras) (NN p21)) (PP (IN in) (NP (DT the) (NN serum)))) (VP (VBD increased) (PP (IN with) (NP (VBN increased) (NN tumor) (NN growth))))) (. .)))
(S1 (S (S (SBAR (IN Since) (S (NP (NN ras) (NNS genes)) (VP (VBP have) (VP (VBN been) (VP (VBN found) (S (VP (TO to) (VP (VB be) (ADVP (RB frequently)) (VP (VBN activated) (PP (IN in) (NP (JJ human) (NNS tumours)))))))))))) (, ,) (NP (PRP we)) (VP (VBD examined) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NN ras) (NN p21)))) (PP (IN in) (NP (NP (DT the) (NN sera)) (PP (IN of) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ human) (NN cancer) (NNS patients))))))))) (. .)))
(S1 (S (S (PP (IN In) (NP (QP (RB only) (CD 3) (IN out) (IN of) (CD 13)) (NNS cases))) (, ,) (PP (VBG representing) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS adenocarcinomas)) (PP (IN of) (NP (NP (DT the) (NN stomach)) (VP (VBG receiving) (NP (NN chemotherapy))))))))) (, ,) (VP (VBD was) (NP (NN ras) (NN p21)) (VP (VBN detected) (PP (IN at) (NP (JJ elevated) (NNS levels))) (, ,) (SBAR (IN whereas) (S (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (DT the) (VBG following) (NNS types)) (PP (IN of) (NP (NN cancer))))))) (NP (NP (DT no) (JJ substantial) (NN change)) (PP (IN in) (NP (NN serum) (NN ras) (NN p21)))) (VP (VBD was) (VP (VBN observed)))))))) (: ;) (NP (NP (CD nine)) (PP (IN with) (NP (NP (NN breast)) (, ,) (NP (CD 5) (NN colon)) (, ,) (NP (CD 5) (NN lung)) (, ,) (NP (CD 5) (JJ ovarian)) (CC and) (NP (CD 5) (JJ hepatocellular) (NNS carcinomas))))) (. .)))
